Literature DB >> 8239522

Depletion of serum methionine by methioninase in mice.

V K Lishko1, O V Lishko, R M Hoffman.   

Abstract

Methionine dependence is a tumor-specific metabolic defect found in human cancer cell lines as well as in fresh human tumor specimens. Methionine dependent tumors cease growing when deprived of methionine, unlike normal cells which can substitute homocysteine for methionine for their growth requirement. We have previously purified a stable, endotoxin-free methioninase from the bacterium, Pseudomonas putida. We demonstrate in this report that purified methioninase can lower the serum levels of methionine in normal and nude mice from 60 microM to approximately 5 microM within 1 hour. The circulating half-life of methioninase is approximately 100 minutes in mice after i.v. injection. The enzyme therefore seems to be a good candidate as an antitumor agent for methionine-dependent tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239522

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Plasma pharmacokinetics and tissue distribution of L-lysine α-oxidase from Trichoderma cf. aureoviride RIFAI VKM F- 4268D in mice.

Authors:  V S Pokrovsky; A N Lukashev; G Babayeva; S Sh Karshieva; A Yu Arinbasarova; A G Medentzev; M V Komarova; E V Lukasheva
Journal:  Amino Acids       Date:  2021-01-04       Impact factor: 3.520

2.  GFP reporter screens for the engineering of amino acid degrading enzymes from libraries expressed in bacteria.

Authors:  Olga Paley; Giulia Agnello; Jason Cantor; Tae Hyun Yoo; George Georgiou; Everett Stone
Journal:  Methods Mol Biol       Date:  2013

3.  De novo engineering of a human cystathionine-γ-lyase for systemic (L)-Methionine depletion cancer therapy.

Authors:  Everett Stone; Olga Paley; Jian Hu; Barbara Ekerdt; Nai-Kong Cheung; George Georgiou
Journal:  ACS Chem Biol       Date:  2012-09-21       Impact factor: 5.100

4.  Methionine depletion with recombinant methioninase: in vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs.

Authors:  Jian Hu; Nai-Kong V Cheung
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

5.  Regulation of O6-methylguanine-DNA methyltransferase by methionine in human tumour cells.

Authors:  D M Kokkinakis; M A von Wronski; T H Vuong; T P Brent; S C Schold
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 6.  L-methionase: a therapeutic enzyme to treat malignancies.

Authors:  Bhupender Sharma; Sukhdev Singh; Shamsher S Kanwar
Journal:  Biomed Res Int       Date:  2014-08-31       Impact factor: 3.411

7.  Antisense inhibition of methylenetetrahydrofolate reductase reduces survival of methionine-dependent tumour lines.

Authors:  J Sekhon; P Pereira; N Sabbaghian; A R Schievella; R Rozen
Journal:  Br J Cancer       Date:  2002-07-15       Impact factor: 7.640

8.  Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model.

Authors:  Kei Kawaguchi; Kentaro Igarashi; Shukuan Li; Qinghong Han; Yuying Tan; Tasuku Kiyuna; Kentaro Miyake; Takashi Murakami; Bartosz Chmielowski; Scott D Nelson; Tara A Russell; Sarah M Dry; Yunfeng Li; Michiaki Unno; Fritz C Eilber; Robert M Hoffman
Journal:  Oncotarget       Date:  2017-08-12

9.  Enhanced anticancer effect of vincristine with methionine infusion after methionine-depleting total parenteral nutrition in tumor-bearing rats.

Authors:  N Goseki; T Nagahama; M Maruyama; M Endo
Journal:  Jpn J Cancer Res       Date:  1996-02

Review 10.  Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma.

Authors:  Robert M Hoffman
Journal:  Int J Mol Sci       Date:  2017-08-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.